Brain+ A/S (CPH:BRAINP)

Market Cap	3.63M -79.9%
Revenue (ttm)	5.80M -4.7%
Net Income	-12.98M
EPS	n/a
Shares Out	1.13B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,152,221
Average Volume	26,583,659
Open	0.0030
Previous Close	0.0032
Day's Range	0.0030 - 0.0032
52-Week Range	0.0010 - 0.0798
Beta	-0.85
RSI	36.82
Earnings Date	Apr 29, 2026

About Brain+

Brain+ A/S, a healthtech company, develops and commercializes technology solutions in dementia care primarily for cognitive stimulation therapy. The company is developing Ayla, a scalable dementia care platform that offers practical, human-centered, and clinically proven software-based dementia therapy and care solutions. It is also developing Ayla – your CST Assistant, a software-based dementia care platform that offers high-quality and scalable cognitive stimulation therapy (CST). The company offers its products to healthcare providers, as we...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2012
• Employees: 12
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: BRAINP

Financial Performance

In 2024, Brain+'s revenue was 7.86 million, an increase of 28.08% compared to the previous year's 6.14 million. Losses were -12.05 million, -37.02% less than in 2023.